​

Funding Round

Series A - DermBiont

Series A - DermBiont

Investment Firm

Overview

DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.

Announced Date

Jun 18, 2019

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Toba Capital

Toba Capital

Toba Capital is a early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

Viking Global Investors

Viking Global Investors

Viking Global Investors is a early_stage_venture and late_stage_venture firm.

Participant Investors

5

Investor Name
Participant InvestorViking Global Investors
Participant InvestorValia Ventures
Participant InvestorMark De Souza
Participant InvestorStart Capital
Participant InvestorToba Capital

Round Details and Background

DermBiont raised $8000000 on 2019-06-18 in Series A

DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 14, 2022
Venture Round - DermBiont
-830.3K
Sep 19, 2022
Debt Financing - DermBiont
-2.5M
Mar 21, 2023
Debt Financing - DermBiont
-4.7M
Oct 19, 2023
Series B - DermBiont
4-35.2M

Recent Activity

There is no recent news or activity for this profile.